Novo's Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial US$ 21.01 Min. order: 1 piece ★★★★★ 5.0 (116 reviews) Sold : Login>>
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity US$ 20.11 Min. order: 1 piece ★★★★★ 4.5 (91 reviews) Sold : Login>>
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues US$ 23.01 Min. order: 1 piece ★★★★★ 4.0 (135 reviews) Sold : Login>>
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management US$ 29.56 Min. order: 1 piece ★★★★★ 4.8 (218 reviews) Sold : Login>>
Novo Nordisk Stock Rises on Trial Results for Cagrilintide Obesity Treatment US$ 22.44 Min. order: 1 piece ★★★★★ 4.8 (260 reviews) Sold : Login>>
Novo Nordisk's CagriSema Falls Short in Head-to-Head Trial vs Zepbound | Bryce Platt, PharmD posted on the topic US$ 28.71 Min. order: 1 piece ★★★★★ 4.5 (265 reviews) Sold : Login>>